| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3729052
Max Phase: Preclinical
Molecular Formula: C15H14Cl2N4O
Molecular Weight: 337.21
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1cccc(NCC(=O)N/N=C/c2c(Cl)cncc2Cl)c1
Standard InChI: InChI=1S/C15H14Cl2N4O/c1-10-3-2-4-11(5-10)19-9-15(22)21-20-6-12-13(16)7-18-8-14(12)17/h2-8,19H,9H2,1H3,(H,21,22)/b20-6+
Standard InChI Key: IANLHQTVNOGKEV-CGOBSMCZSA-N
Associated Targets(Human)
GRK2 Tchem G-protein coupled receptor kinase 2 (1019 Activities)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 337.21 | Molecular Weight (Monoisotopic): 336.0545 | AlogP: 3.26 | #Rotatable Bonds: 5 |
| Polar Surface Area: 66.38 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 11.69 | CX Basic pKa: 2.11 | CX LogP: 2.76 | CX LogD: 2.76 |
| Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.65 | Np Likeness Score: -2.14 |
References
| 1. (2007) Hydrazide compounds, |
Source
Source(1):